Coronary Disease News and Research

RSS

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".

31 Aug 2010

Adoption of standby intra-aortic balloon pump strategy during high-risk PCI needed: Study

High-risk patients undergoing a coronary procedure such as placement of a stent who electively received an intra-aortic balloon pump (a device that can help improve blood flow) prior to the procedure did not experience a significantly lower overall rate of events such as heart attack, revascularization or death, according to a study in the August 25 issue of JAMA.

25 Aug 2010

25% of stroke patients stop taking prevention medication within 3 months

At least a quarter of patients who have suffered a stroke stop taking one or more of their prescribed stroke prevention medications within the first three months after being hospitalized - when the chance of having another stroke is highest - according to a new study by researchers at Wake Forest University Baptist Medical Center and colleagues.

12 Aug 2010

Ultrafine particle exposure may contribute to coronary heart disease risk in firefighters: Research

Exposure to high levels of ultrafine particles—invisible particles that can reach the smallest air passages in the lungs—may be an important contributor to the risk of coronary heart disease in firefighters, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

12 Aug 2010

Modifiable factors associated with stroke survivor compliance to taking medication: Study

12 Aug 2010

SORT1 pathway holds promise as new target for therapeutic intervention for LDL cholesterol reduction

The true power of genomic research lies in its ability to help scientists understand biological processes, particularly those that - when altered - can lead to disease. This power is demonstrated dramatically in a pair of papers published today in the journal Nature. In the first, a global team of researchers describes 95 different variations across the genome that contribute in different degrees to alterations in blood cholesterol and triglyceride levels in multiple human populations. In the second report, close examination of just one of these common variants not only reveals the involvement of an unexpected genetic pathway in lipid metabolism but also provides a blueprint for using genomic findings to unravel biological connections between lipid levels and coronary heart disease.

5 Aug 2010

Living with children has a negative influence on parents' ability to exercise: Study

A study conducted at the Montreal Heart Institute has shown unexpectedly that living with children is linked to a reduction in physical activity. Carried out with 756 participants and led by Dr. Simon L. Bacon, Associate Researcher at the MHI and Professor at Concordia University, the study assessed the impact of social networks on exercise, revealing that people with heart disease who live with children exercise less than those people who do not live with children.

21 Jul 2010

Heart patients living with children exercise less: Study

A study conducted at the Montreal Heart Institute (MHI) has shown unexpectedly that living with children is linked to a reduction in physical activity. Carried out with 756 participants and led by Dr. Simon L. Bacon, Associate Researcher at the MHI and Professor at Concordia University, the study assessed the impact of social networks on exercise, revealing that people with heart disease who live with children exercise less than those people who do not live with children.

20 Jul 2010

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009.

15 Jul 2010

Older men with high testosterone levels more likely to have heart attacks

A large U.S. multicenter study shows that older men with higher testosterone levels are more likely to have a heart attack or other cardiovascular disease in the future. The results were presented at The Endocrine Society's 92nd Annual Meeting in San Diego.

2 Jul 2010

Eating Mediterranean-style diet reduces heart disease risk: Research

A study of twins shows that even with genes that put them at higher risk of cardiovascular disease, eating a Mediterranean-style diet can improve heart function, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

16 Jun 2010

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

At 12 months the NEVO™ Sirolimus-eluting Coronary Stent has continued to demonstrate excellent safety and efficacy outcomes compared to Taxus® Liberte® according to new data presented today from the NEVO™ RES-I clinical trial. These results were presented as a late breaking trial at EuroPCR, the leading medical conference in Europe for physicians specializing in interventional cardiovascular medicine.

26 May 2010

Lack of discussion on resuming sex after heart attack associated with less sexual activity

Sexual activity declines in the year after heart attack for patients who don't get instructions from their doctors about when it's safe to resume sex, researchers reported at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

21 May 2010

Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease

A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010. The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated with an increased risk of coronary heart disease similar in magnitude to that with non-HDL cholesterol or systolic blood pressure.

20 May 2010

Framingham risk assessment tool fails to predict patients with suspected CAD: Study

If patients with suspected coronary artery disease are excluded from further screening because of a low Framingham score, many patients with substantial atherosclerosis (a build-up of plaque inside the arteries) will be missed, according to a study published in the May issue of the American Journal of Roentgenology.

22 Apr 2010

New book exposes the ignored causes of three major life-threatening and chronic diseases

In his newest book, "Overlooked Causes and the Prevention: Cancer, Cardiovascular Heart Disease, Multiple Sclerosis" (published by AuthorHouse), author Arthur Douglass Alexander III exposes, delineates and documents the sometimes overlooked and often ignored causes of three major life-threatening and chronic diseases: cancer, cardiovascular disease and multiple sclerosis.

18 Mar 2010

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale of its AttriusTM PET scanner to Ochsner Health System of Louisiana.

5 Mar 2010

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.

9 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

3 Feb 2010

Coronary Disease News and Research

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Adoption of standby intra-aortic balloon pump strategy during high-risk PCI needed: Study

25% of stroke patients stop taking prevention medication within 3 months

Ultrafine particle exposure may contribute to coronary heart disease risk in firefighters: Research

Modifiable factors associated with stroke survivor compliance to taking medication: Study

SORT1 pathway holds promise as new target for therapeutic intervention for LDL cholesterol reduction

Living with children has a negative influence on parents' ability to exercise: Study

Heart patients living with children exercise less: Study

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Older men with high testosterone levels more likely to have heart attacks

Eating Mediterranean-style diet reduces heart disease risk: Research

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

Lack of discussion on resuming sex after heart attack associated with less sexual activity

Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease

Framingham risk assessment tool fails to predict patients with suspected CAD: Study

New book exposes the ignored causes of three major life-threatening and chronic diseases

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News